The role of age and exposure to Plasmodium falciparum in the rate of acquisition of naturally acquired immunity: a randomized controlled trial.
The rate of acquisition of naturally acquired immunity (NAI) against malaria predominantly depends on transmission intensity and age, although disentangling the effects of these is difficult. We used chemoprophylaxis to selectively control exposure to P. falciparum during different periods in infanc...
Main Authors: | , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3296698?pdf=render |
id |
doaj-c8b9e3d0df0d4998a97eafe06f467fde |
---|---|
record_format |
Article |
spelling |
doaj-c8b9e3d0df0d4998a97eafe06f467fde2020-11-24T21:30:04ZengPublic Library of Science (PLoS)PLoS ONE1932-62032012-01-0173e3236210.1371/journal.pone.0032362The role of age and exposure to Plasmodium falciparum in the rate of acquisition of naturally acquired immunity: a randomized controlled trial.Caterina GuinovartCarlota DobañoQuique BassatAugusto NhabombaLlorenç QuintóMaria Nélia ManacaRuth AguilarMauricio H RodríguezArnoldo BarbosaJohn J AponteAlfredo G MayorMontse RenomCinta MoraledaDavid J RobertsEvelin SchwarzerPeter N Le SouëfLouis SchofieldChetan E ChitnisDenise L DoolanPedro L AlonsoThe rate of acquisition of naturally acquired immunity (NAI) against malaria predominantly depends on transmission intensity and age, although disentangling the effects of these is difficult. We used chemoprophylaxis to selectively control exposure to P. falciparum during different periods in infancy and explore the effect of age in the build-up of NAI, measured as risk of clinical malaria.A three-arm double-blind randomized placebo-controlled trial was conducted in 349 infants born to Mozambican HIV-negative women. The late exposure group (LEG) received monthly Sulfadoxine-Pyrimethamine (SP) plus Artesunate (AS) from 2.5-4.5 months of age and monthly placebo from 5.5-9.5 months; the early exposure group (EEG) received placebo from 2.5-4.5 months and SP+AS from 5.5-9.5 months; and the control group (CG) received placebo from 2.5-9.5 months. Active and passive case detection (PCD) were conducted from birth to 10.5 and 24 months respectively. The primary endpoint was time to first or only episode of malaria in the second year detected by PCD. The incidence of malaria during the second year was of 0.50, 0.51 and 0.35 episodes/PYAR in the LEG, EEG and CG respectively (p = 0.379 for the adjusted comparison of the 3 groups). The hazard ratio of the adjusted comparison between the LEG and the CG was 1.38 (0.83-2.28, p = 0.642) and that between the EEG and the CG was 1.35 (0.81-2.24, p = 0.743).After considerably interfering with exposure during the first year of life, there was a trend towards a higher risk of malaria in the second year in children who had received chemoprophylaxis, but there was no significant rebound. No evidence was found that the age of first exposure to malaria affects the rate of acquisition of NAI. Thus, the timing of administration of antimalarial interventions like malaria vaccines during infancy does not appear to be a critical determinant.ClinicalTrials.gov NCT00231452.http://europepmc.org/articles/PMC3296698?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Caterina Guinovart Carlota Dobaño Quique Bassat Augusto Nhabomba Llorenç Quintó Maria Nélia Manaca Ruth Aguilar Mauricio H Rodríguez Arnoldo Barbosa John J Aponte Alfredo G Mayor Montse Renom Cinta Moraleda David J Roberts Evelin Schwarzer Peter N Le Souëf Louis Schofield Chetan E Chitnis Denise L Doolan Pedro L Alonso |
spellingShingle |
Caterina Guinovart Carlota Dobaño Quique Bassat Augusto Nhabomba Llorenç Quintó Maria Nélia Manaca Ruth Aguilar Mauricio H Rodríguez Arnoldo Barbosa John J Aponte Alfredo G Mayor Montse Renom Cinta Moraleda David J Roberts Evelin Schwarzer Peter N Le Souëf Louis Schofield Chetan E Chitnis Denise L Doolan Pedro L Alonso The role of age and exposure to Plasmodium falciparum in the rate of acquisition of naturally acquired immunity: a randomized controlled trial. PLoS ONE |
author_facet |
Caterina Guinovart Carlota Dobaño Quique Bassat Augusto Nhabomba Llorenç Quintó Maria Nélia Manaca Ruth Aguilar Mauricio H Rodríguez Arnoldo Barbosa John J Aponte Alfredo G Mayor Montse Renom Cinta Moraleda David J Roberts Evelin Schwarzer Peter N Le Souëf Louis Schofield Chetan E Chitnis Denise L Doolan Pedro L Alonso |
author_sort |
Caterina Guinovart |
title |
The role of age and exposure to Plasmodium falciparum in the rate of acquisition of naturally acquired immunity: a randomized controlled trial. |
title_short |
The role of age and exposure to Plasmodium falciparum in the rate of acquisition of naturally acquired immunity: a randomized controlled trial. |
title_full |
The role of age and exposure to Plasmodium falciparum in the rate of acquisition of naturally acquired immunity: a randomized controlled trial. |
title_fullStr |
The role of age and exposure to Plasmodium falciparum in the rate of acquisition of naturally acquired immunity: a randomized controlled trial. |
title_full_unstemmed |
The role of age and exposure to Plasmodium falciparum in the rate of acquisition of naturally acquired immunity: a randomized controlled trial. |
title_sort |
role of age and exposure to plasmodium falciparum in the rate of acquisition of naturally acquired immunity: a randomized controlled trial. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2012-01-01 |
description |
The rate of acquisition of naturally acquired immunity (NAI) against malaria predominantly depends on transmission intensity and age, although disentangling the effects of these is difficult. We used chemoprophylaxis to selectively control exposure to P. falciparum during different periods in infancy and explore the effect of age in the build-up of NAI, measured as risk of clinical malaria.A three-arm double-blind randomized placebo-controlled trial was conducted in 349 infants born to Mozambican HIV-negative women. The late exposure group (LEG) received monthly Sulfadoxine-Pyrimethamine (SP) plus Artesunate (AS) from 2.5-4.5 months of age and monthly placebo from 5.5-9.5 months; the early exposure group (EEG) received placebo from 2.5-4.5 months and SP+AS from 5.5-9.5 months; and the control group (CG) received placebo from 2.5-9.5 months. Active and passive case detection (PCD) were conducted from birth to 10.5 and 24 months respectively. The primary endpoint was time to first or only episode of malaria in the second year detected by PCD. The incidence of malaria during the second year was of 0.50, 0.51 and 0.35 episodes/PYAR in the LEG, EEG and CG respectively (p = 0.379 for the adjusted comparison of the 3 groups). The hazard ratio of the adjusted comparison between the LEG and the CG was 1.38 (0.83-2.28, p = 0.642) and that between the EEG and the CG was 1.35 (0.81-2.24, p = 0.743).After considerably interfering with exposure during the first year of life, there was a trend towards a higher risk of malaria in the second year in children who had received chemoprophylaxis, but there was no significant rebound. No evidence was found that the age of first exposure to malaria affects the rate of acquisition of NAI. Thus, the timing of administration of antimalarial interventions like malaria vaccines during infancy does not appear to be a critical determinant.ClinicalTrials.gov NCT00231452. |
url |
http://europepmc.org/articles/PMC3296698?pdf=render |
work_keys_str_mv |
AT caterinaguinovart theroleofageandexposuretoplasmodiumfalciparumintherateofacquisitionofnaturallyacquiredimmunityarandomizedcontrolledtrial AT carlotadobano theroleofageandexposuretoplasmodiumfalciparumintherateofacquisitionofnaturallyacquiredimmunityarandomizedcontrolledtrial AT quiquebassat theroleofageandexposuretoplasmodiumfalciparumintherateofacquisitionofnaturallyacquiredimmunityarandomizedcontrolledtrial AT augustonhabomba theroleofageandexposuretoplasmodiumfalciparumintherateofacquisitionofnaturallyacquiredimmunityarandomizedcontrolledtrial AT llorencquinto theroleofageandexposuretoplasmodiumfalciparumintherateofacquisitionofnaturallyacquiredimmunityarandomizedcontrolledtrial AT marianeliamanaca theroleofageandexposuretoplasmodiumfalciparumintherateofacquisitionofnaturallyacquiredimmunityarandomizedcontrolledtrial AT ruthaguilar theroleofageandexposuretoplasmodiumfalciparumintherateofacquisitionofnaturallyacquiredimmunityarandomizedcontrolledtrial AT mauriciohrodriguez theroleofageandexposuretoplasmodiumfalciparumintherateofacquisitionofnaturallyacquiredimmunityarandomizedcontrolledtrial AT arnoldobarbosa theroleofageandexposuretoplasmodiumfalciparumintherateofacquisitionofnaturallyacquiredimmunityarandomizedcontrolledtrial AT johnjaponte theroleofageandexposuretoplasmodiumfalciparumintherateofacquisitionofnaturallyacquiredimmunityarandomizedcontrolledtrial AT alfredogmayor theroleofageandexposuretoplasmodiumfalciparumintherateofacquisitionofnaturallyacquiredimmunityarandomizedcontrolledtrial AT montserenom theroleofageandexposuretoplasmodiumfalciparumintherateofacquisitionofnaturallyacquiredimmunityarandomizedcontrolledtrial AT cintamoraleda theroleofageandexposuretoplasmodiumfalciparumintherateofacquisitionofnaturallyacquiredimmunityarandomizedcontrolledtrial AT davidjroberts theroleofageandexposuretoplasmodiumfalciparumintherateofacquisitionofnaturallyacquiredimmunityarandomizedcontrolledtrial AT evelinschwarzer theroleofageandexposuretoplasmodiumfalciparumintherateofacquisitionofnaturallyacquiredimmunityarandomizedcontrolledtrial AT peternlesouef theroleofageandexposuretoplasmodiumfalciparumintherateofacquisitionofnaturallyacquiredimmunityarandomizedcontrolledtrial AT louisschofield theroleofageandexposuretoplasmodiumfalciparumintherateofacquisitionofnaturallyacquiredimmunityarandomizedcontrolledtrial AT chetanechitnis theroleofageandexposuretoplasmodiumfalciparumintherateofacquisitionofnaturallyacquiredimmunityarandomizedcontrolledtrial AT deniseldoolan theroleofageandexposuretoplasmodiumfalciparumintherateofacquisitionofnaturallyacquiredimmunityarandomizedcontrolledtrial AT pedrolalonso theroleofageandexposuretoplasmodiumfalciparumintherateofacquisitionofnaturallyacquiredimmunityarandomizedcontrolledtrial AT caterinaguinovart roleofageandexposuretoplasmodiumfalciparumintherateofacquisitionofnaturallyacquiredimmunityarandomizedcontrolledtrial AT carlotadobano roleofageandexposuretoplasmodiumfalciparumintherateofacquisitionofnaturallyacquiredimmunityarandomizedcontrolledtrial AT quiquebassat roleofageandexposuretoplasmodiumfalciparumintherateofacquisitionofnaturallyacquiredimmunityarandomizedcontrolledtrial AT augustonhabomba roleofageandexposuretoplasmodiumfalciparumintherateofacquisitionofnaturallyacquiredimmunityarandomizedcontrolledtrial AT llorencquinto roleofageandexposuretoplasmodiumfalciparumintherateofacquisitionofnaturallyacquiredimmunityarandomizedcontrolledtrial AT marianeliamanaca roleofageandexposuretoplasmodiumfalciparumintherateofacquisitionofnaturallyacquiredimmunityarandomizedcontrolledtrial AT ruthaguilar roleofageandexposuretoplasmodiumfalciparumintherateofacquisitionofnaturallyacquiredimmunityarandomizedcontrolledtrial AT mauriciohrodriguez roleofageandexposuretoplasmodiumfalciparumintherateofacquisitionofnaturallyacquiredimmunityarandomizedcontrolledtrial AT arnoldobarbosa roleofageandexposuretoplasmodiumfalciparumintherateofacquisitionofnaturallyacquiredimmunityarandomizedcontrolledtrial AT johnjaponte roleofageandexposuretoplasmodiumfalciparumintherateofacquisitionofnaturallyacquiredimmunityarandomizedcontrolledtrial AT alfredogmayor roleofageandexposuretoplasmodiumfalciparumintherateofacquisitionofnaturallyacquiredimmunityarandomizedcontrolledtrial AT montserenom roleofageandexposuretoplasmodiumfalciparumintherateofacquisitionofnaturallyacquiredimmunityarandomizedcontrolledtrial AT cintamoraleda roleofageandexposuretoplasmodiumfalciparumintherateofacquisitionofnaturallyacquiredimmunityarandomizedcontrolledtrial AT davidjroberts roleofageandexposuretoplasmodiumfalciparumintherateofacquisitionofnaturallyacquiredimmunityarandomizedcontrolledtrial AT evelinschwarzer roleofageandexposuretoplasmodiumfalciparumintherateofacquisitionofnaturallyacquiredimmunityarandomizedcontrolledtrial AT peternlesouef roleofageandexposuretoplasmodiumfalciparumintherateofacquisitionofnaturallyacquiredimmunityarandomizedcontrolledtrial AT louisschofield roleofageandexposuretoplasmodiumfalciparumintherateofacquisitionofnaturallyacquiredimmunityarandomizedcontrolledtrial AT chetanechitnis roleofageandexposuretoplasmodiumfalciparumintherateofacquisitionofnaturallyacquiredimmunityarandomizedcontrolledtrial AT deniseldoolan roleofageandexposuretoplasmodiumfalciparumintherateofacquisitionofnaturallyacquiredimmunityarandomizedcontrolledtrial AT pedrolalonso roleofageandexposuretoplasmodiumfalciparumintherateofacquisitionofnaturallyacquiredimmunityarandomizedcontrolledtrial |
_version_ |
1725964127670632448 |